NCT03047447View on ClinicalTrials.gov

Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 25, 2016

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Metabolic SyndromeDiabetes Mellitus, Type 2Pre Diabetes
Interventions
BEHAVIORAL

Dietary Ketosis: Regulator of Obesity and Metabolic Syndrome

30 adults previously diagnosed with MetS randomly prescribed to one of three groups: a sustained ketogenic diet with no exercise, the participant's normal diet with no exercise, or participant's normal diet with 3-5 days per week of exercise for 30 minutes

Trial Locations (1)

55311

Bristlecone Behavioral Health, Inc., Maple Grove

All Listed Sponsors
collaborator

University of Minnesota

OTHER

lead

Bristlecone Behavioral Health, Inc.

INDUSTRY

NCT03047447 - Induced and Controlled Dietary Ketosis as a Regulator of Obesity and Metabolic Syndrome Pathologies | Biotech Hunter | Biotech Hunter